- Elanco Animal Health (NYSE:ELAN) on Tuesday hit another 52-week low, this time to $16.05.
- Since August 4, the company has reached a new 52-week low seven times.
- Although Elanco (ELAN) beat on the top line in its recent Q2 2022 results, it also narrowed its fiscal 2022 guidance in regards to revenue and EPS.
- The company also was downgraded by two Street firms this month. JP Morgan cut the stock to neutral from overweight citing better opportunities in the animal health space. Morgan Stanley cut the stock to equal weight from overweight due to growth concerns.
- Seeking Alpha Quant Rating views Elanco as a hold with high grades for growth and profitability.
Elanco Animal Health hits another 52-week low. What's going on with the company?
Recommended For You
About ELAN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ELAN | - | - |
Elanco Animal Health Incorporated |